Pentobarbital 25 mg/mL oral suspension
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Pentobarbital sodium | active | 2.5 g |
| SyrSpend SF Alka | vehicle | q.s. to 100 mL |
- Strength
- 25 mg/mL
- Starting material
- Pentobarbital sodium bulk powder
- Container
- Original vehicle container (see the study)
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 120 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
| Room temperature | 120 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
Querin B, Schweitzer-Chaput A, Nedjar C, Schlatter J. Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure. Data Brief. 2021;35:106884. PMID 33681434. PMC7910507. License: CC BY (checked 2026-11-06). Read the article · DOI
For licensed clinicians. Use with clinical judgment.